This is a Validated Antibody Database (VAD) review about human CCR5, based on 54 published articles (read how Labome selects the articles), using CCR5 antibody in all methods. It is aimed to help Labome visitors find the most suited CCR5 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CCR5 synonym: CC-CKR-5; CCCKR5; CCR-5; CD195; CKR-5; CKR5; CMKBR5; IDDM22

others
  • flow cytometry; human; loading ...; fig 1b
 CCR5 antibody (R&D Systems, 45531) was used in flow cytometry on human samples (fig 1b). Cell Death Dis (2019) ncbi
BioLegend
rat monoclonal (J418F1)
  • flow cytometry; human
BioLegend CCR5 antibody (Biolegend, 359118) was used in flow cytometry on human samples . elife (2020) ncbi
rat monoclonal (J418F1)
  • flow cytometry; human; loading ...; fig 2a, 4b
BioLegend CCR5 antibody (BioLegend, J418F1) was used in flow cytometry on human samples (fig 2a, 4b). Rheumatology (Oxford) (2020) ncbi
rat monoclonal (HEK/1/85a)
  • flow cytometry; human; loading ...; fig 2b
BioLegend CCR5 antibody (BioLegend, HEK/1/85a) was used in flow cytometry on human samples (fig 2b). Front Immunol (2019) ncbi
rat monoclonal (HEK/1/85a)
  • flow cytometry; human; 1:100; loading ...; fig 3s2
BioLegend CCR5 antibody (Biolegend, 313707) was used in flow cytometry on human samples at 1:100 (fig 3s2). elife (2019) ncbi
rat monoclonal (HEK/1/85a)
  • flow cytometry; human; 1:100; loading ...; fig s5g
BioLegend CCR5 antibody (Biolegend, 313707) was used in flow cytometry on human samples at 1:100 (fig s5g). Cancer Cell (2019) ncbi
rat monoclonal (J418F1)
  • flow cytometry; human; loading ...; fig 2
BioLegend CCR5 antibody (BioLegend, 359,107) was used in flow cytometry on human samples (fig 2). Immun Ageing (2017) ncbi
rat monoclonal (J418F1)
  • flow cytometry; human; loading ...; fig s1
In order to evaluate the effectiveness of adoptive natural killer cell therapy against the pulmonary metastasis of Ewing sarcoma, BioLegend CCR5 antibody (BioLegend, J418F1) was used in flow cytometry on human samples (fig s1). Oncoimmunology (2017) ncbi
rat monoclonal (J418F1)
  • flow cytometry; human; fig 1e
In order to investigate the role of Eomes in the retention of liver natural killer cells, BioLegend CCR5 antibody (BioLegend, J418F1) was used in flow cytometry on human samples (fig 1e). J Immunol (2016) ncbi
rat monoclonal (HEK/1/85a)
  • flow cytometry; human; 1:100; fig 3
BioLegend CCR5 antibody (BioLegend, 313712) was used in flow cytometry on human samples at 1:100 (fig 3). Mol Ther Methods Clin Dev (2016) ncbi
rat monoclonal (HEK/1/85a)
  • flow cytometry; human; loading ...; fig 4a
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend CCR5 antibody (biolegend, HEK/1/85a) was used in flow cytometry on human samples (fig 4a). J Immunol (2016) ncbi
rat monoclonal (HEK/1/85a)
  • flow cytometry; human; 1:200; fig s4
BioLegend CCR5 antibody (Biolegend, HEK/1/85a) was used in flow cytometry on human samples at 1:200 (fig s4). Nat Commun (2015) ncbi
rat monoclonal (HEK/1/85a)
  • flow cytometry; human; fig 3
In order to investigate the dynamics and characteristics of natural killer cell types in the human ocular mucosal surface in situ during infection with group D human adenoviruses, BioLegend CCR5 antibody (Biolegend, HEK/185a) was used in flow cytometry on human samples (fig 3). Mucosal Immunol (2016) ncbi
rat monoclonal (HEK/1/85a)
  • flow cytometry; human; 1:50
BioLegend CCR5 antibody (BioLegend, 313705) was used in flow cytometry on human samples at 1:50. Mol Cancer Res (2015) ncbi
rat monoclonal (HEK/1/85a)
  • flow cytometry; human; fig 4
BioLegend CCR5 antibody (Biolegend, HEK/1/85a) was used in flow cytometry on human samples (fig 4). Biochem Biophys Res Commun (2015) ncbi
rat monoclonal (HEK/1/85a)
  • flow cytometry; human
BioLegend CCR5 antibody (Biolegend, HEK/1/85a) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
rat monoclonal (HEK/1/85a)
BioLegend CCR5 antibody (Biolegend, HEK/1/85a) was used . Proc Natl Acad Sci U S A (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (D-6)
  • immunohistochemistry; mouse; loading ...; fig 6h
Santa Cruz Biotechnology CCR5 antibody (Santa Cruz Biotechnology, sc-17833) was used in immunohistochemistry on mouse samples (fig 6h). Proc Natl Acad Sci U S A (2021) ncbi
Invitrogen
mouse monoclonal (eBioT21/8 (T21/8))
  • flow cytometry; mouse; 1:200; loading ...; fig s5a
Invitrogen CCR5 antibody (Affymetrix/eBioscience, T21/8) was used in flow cytometry on mouse samples at 1:200 (fig s5a). J Clin Invest (2018) ncbi
mouse monoclonal (eBioT21/8 (T21/8))
  • flow cytometry; human
Invitrogen CCR5 antibody (eBioscience, eBioT21/8) was used in flow cytometry on human samples . Eur J Immunol (2014) ncbi
Novus Biologicals
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; rhesus macaque; fig 6
In order to investigate the mechanisms by which methamphetamine contributes to the pro-inflammatory central nervous system environment in macaques infected with the simian immunodeficiency virus, Novus Biologicals CCR5 antibody (Novus Biologicals, NBP2-31374) was used in immunohistochemistry - paraffin section on rhesus macaque samples (fig 6). BMC Immunol (2016) ncbi
BD Biosciences
mouse monoclonal (3A9)
  • flow cytometry; African green monkey; loading ...; fig 2b
BD Biosciences CCR5 antibody (BD Pharmingen, 556042) was used in flow cytometry on African green monkey samples (fig 2b). PLoS Pathog (2020) ncbi
mouse monoclonal (2D7/CCR5)
  • flow cytometry; human; loading ...; fig 3d
BD Biosciences CCR5 antibody (BD Pharmingen, 560935) was used in flow cytometry on human samples (fig 3d). elife (2019) ncbi
mouse monoclonal (3A9)
  • flow cytometry; human; loading ...; fig 2b
BD Biosciences CCR5 antibody (BD Biosciences, 3A9) was used in flow cytometry on human samples (fig 2b). JCI Insight (2019) ncbi
mouse monoclonal (2D7/CCR5)
  • flow cytometry; human; loading ...; fig 4h
In order to detail MAIT cell responses to various microorganisms and cytokines, BD Biosciences CCR5 antibody (BD Biosciences, 2D7/CCR5) was used in flow cytometry on human samples (fig 4h). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (2D7/CCR5)
  • flow cytometry; human; loading ...; fig 5b
BD Biosciences CCR5 antibody (BD Biosciences, 2D7/CCR5) was used in flow cytometry on human samples (fig 5b). AIDS Res Hum Retroviruses (2017) ncbi
mouse monoclonal (2D7/CCR5)
  • flow cytometry; human; fig 1
BD Biosciences CCR5 antibody (BD Biosciences, 555993) was used in flow cytometry on human samples (fig 1). J Cell Physiol (2017) ncbi
mouse monoclonal (2D7/CCR5)
  • flow cytometry; human; fig 1c
BD Biosciences CCR5 antibody (Becton Dickinson, 2D7) was used in flow cytometry on human samples (fig 1c). Nat Genet (2017) ncbi
mouse monoclonal (3A9)
  • flow cytometry; human; fig 3c
BD Biosciences CCR5 antibody (Becton Dickinson, 3A9) was used in flow cytometry on human samples (fig 3c). Nat Genet (2017) ncbi
mouse monoclonal (2D7/CCR5)
  • flow cytometry; human; loading ...; fig 6b
In order to generate cell line to examine the molecular events controlling HIV expression in the microglia, BD Biosciences CCR5 antibody (BD, 556889) was used in flow cytometry on human samples (fig 6b). J Neurovirol (2017) ncbi
mouse monoclonal (2D7/CCR5)
  • flow cytometry; human; loading ...; tbl 3
BD Biosciences CCR5 antibody (BD Pharmingen, 2D7/CCR5) was used in flow cytometry on human samples (tbl 3). Brain Behav (2016) ncbi
mouse monoclonal (3A9)
  • flow cytometry; rhesus macaque; loading ...; fig s9d
In order to assess the efficacy of targeting alpha4 beta7 integrin to treat SIV, BD Biosciences CCR5 antibody (BD Pharmingen, 556042) was used in flow cytometry on rhesus macaque samples (fig s9d). Science (2016) ncbi
mouse monoclonal (2D7/CCR5)
  • flow cytometry; human; loading ...; fig 1a
In order to demonstrate a novel mechanism by which HIV-1 invades ocular tissues and promotes translocation or invasion by additional pathogens, BD Biosciences CCR5 antibody (BD Pharmingen, 2D7) was used in flow cytometry on human samples (fig 1a). J Biol Chem (2016) ncbi
mouse monoclonal (2D7/CCR5)
  • flow cytometry; human; fig 5c
BD Biosciences CCR5 antibody (BD Biosciences, 2D7/CCR5) was used in flow cytometry on human samples (fig 5c). J Immunol (2016) ncbi
mouse monoclonal (2D7/CCR5)
  • flow cytometry; human; loading ...; fig 1d
BD Biosciences CCR5 antibody (BD Biosciences, 561747) was used in flow cytometry on human samples (fig 1d). PLoS ONE (2016) ncbi
mouse monoclonal (3A9)
  • flow cytometry; rhesus macaque; loading ...
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, BD Biosciences CCR5 antibody (BD Bioscience, 3A9) was used in flow cytometry on rhesus macaque samples . Nat Med (2016) ncbi
mouse monoclonal (3A9)
  • flow cytometry; African green monkey; loading ...; fig s1
In order to discuss the use of flow cytometry to examine common marmosets, BD Biosciences CCR5 antibody (BD, 3A9) was used in flow cytometry on African green monkey samples (fig s1). J Med Primatol (2016) ncbi
mouse monoclonal (3A9)
  • flow cytometry; human; loading ...; fig 3
In order to demonstrate that effector T-cell accumulation and TCR repertoire diversity reduction precede the development of foot ulcers in diabetic patients, BD Biosciences CCR5 antibody (Pharmingen, 3A9) was used in flow cytometry on human samples (fig 3). Cell Mol Immunol (2017) ncbi
mouse monoclonal (3A9)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CCR5 antibody (BD, 556042) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (3A9)
  • flow cytometry; rat; fig 2
BD Biosciences CCR5 antibody (BD Biosciences, 560932) was used in flow cytometry on rat samples (fig 2). J Mater Sci Mater Med (2016) ncbi
mouse monoclonal (3A9)
  • flow cytometry; rhesus macaque; fig s1
BD Biosciences CCR5 antibody (BD Biosciences Pharmingen, 3A9) was used in flow cytometry on rhesus macaque samples (fig s1). Mucosal Immunol (2016) ncbi
mouse monoclonal (2D7/CCR5)
  • flow cytometry; human; fig 3a
In order to analyze HIV progression traits of a selective loss of early differentiated and highly functional PD1high CD4 T cells, BD Biosciences CCR5 antibody (BD Biosciences, 2D7) was used in flow cytometry on human samples (fig 3a). PLoS ONE (2015) ncbi
mouse monoclonal (3A9)
  • flow cytometry; human; fig 1
BD Biosciences CCR5 antibody (BD Biosciences, 550856) was used in flow cytometry on human samples (fig 1). Genome Biol (2015) ncbi
mouse monoclonal (2D7/CCR5)
  • flow cytometry; human; fig 8
BD Biosciences CCR5 antibody (BD Biosciences, 557752) was used in flow cytometry on human samples (fig 8). Retrovirology (2015) ncbi
mouse monoclonal (2D7/CCR5)
  • flow cytometry; human; fig 3,4,5
BD Biosciences CCR5 antibody (BD, 557755) was used in flow cytometry on human samples (fig 3,4,5). Nucleic Acids Res (2015) ncbi
mouse monoclonal (2D7/CCR5)
  • flow cytometry; hamsters; fig 3
BD Biosciences CCR5 antibody (BD Pharmingen, 2D7) was used in flow cytometry on hamsters samples (fig 3). J Gen Virol (2015) ncbi
mouse monoclonal (2D7/CCR5)
  • flow cytometry; human; tbl s1
In order to examine the early impact of viral replicative capacity on HIV-1 immunopathogenesis, BD Biosciences CCR5 antibody (BD Biosciences, 2D7) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (3A9)
  • flow cytometry; human; tbl s3
In order to examine the early impact of viral replicative capacity on HIV-1 immunopathogenesis, BD Biosciences CCR5 antibody (BD Biosciences, 3A9) was used in flow cytometry on human samples (tbl s3). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (2D7/CCR5)
  • flow cytometry; human; fig 2
BD Biosciences CCR5 antibody (BD Biosciences, 2D7/CCR5) was used in flow cytometry on human samples (fig 2). J Autoimmun (2015) ncbi
mouse monoclonal (3A9)
  • flow cytometry; rhesus macaque
In order to examine the mechanism of anti-alpha4 antibody treatment in monkeys, BD Biosciences CCR5 antibody (BD Biosciences, 3A9) was used in flow cytometry on rhesus macaque samples . PLoS Pathog (2014) ncbi
mouse monoclonal (2D7/CCR5)
  • flow cytometry; human; fig 3
BD Biosciences CCR5 antibody (BD Biosciences, 2D7/CCR5) was used in flow cytometry on human samples (fig 3). Nephrol Dial Transplant (2015) ncbi
mouse monoclonal (3A9)
  • flow cytometry; rhesus macaque
BD Biosciences CCR5 antibody (BD Biosciences, 3A9) was used in flow cytometry on rhesus macaque samples . J Immunol (2014) ncbi
mouse monoclonal (3A9)
  • flow cytometry; rhesus macaque
BD Biosciences CCR5 antibody (BD Pharmingen, 550632) was used in flow cytometry on rhesus macaque samples . J Virol (2014) ncbi
mouse monoclonal (2D7/CCR5)
  • flow cytometry; human; loading ...; fig 4a
In order to elucidate the relationship between female genital schistosomiasis and HIV infection, BD Biosciences CCR5 antibody (BD, 2D7/CCR5) was used in flow cytometry on human samples (fig 4a). PLoS ONE (2014) ncbi
mouse monoclonal (3A9)
  • flow cytometry; rhesus macaque
BD Biosciences CCR5 antibody (BD Biosciences, 3A9) was used in flow cytometry on rhesus macaque samples . J Immunol (2014) ncbi
mouse monoclonal (3A9)
  • flow cytometry; chimpanzee
In order to study the in vitro response of gammadelta T-cell subsets from HIV1-infected and control chimpanzees to T-cell activators, BD Biosciences CCR5 antibody (BD Biosciences, 3A9) was used in flow cytometry on chimpanzee samples . J Med Primatol (2014) ncbi
Articles Reviewed
  1. Xie L, Yin Y, Benowitz L. Chemokine CCL5 promotes robust optic nerve regeneration and mediates many of the effects of CNTF gene therapy. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  2. Neidleman J, Luo X, Frouard J, Xie G, Hsiao F, Ma T, et al. Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir. elife. 2020;9: pubmed publisher
  3. Kim J, Jeong J, Jung J, Jeon H, Lee S, Lim J, et al. Immunological characteristics and possible pathogenic role of urinary CD11c+ macrophages in lupus nephritis. Rheumatology (Oxford). 2020;: pubmed publisher
  4. Raehtz K, Barrenas F, Xu C, Busman Sahay K, Valentine A, Law L, et al. African green monkeys avoid SIV disease progression by preventing intestinal dysfunction and maintaining mucosal barrier integrity. PLoS Pathog. 2020;16:e1008333 pubmed publisher
  5. Liberatore R, Mastrocola E, Cassella E, Schmidt F, Willen J, Voronin D, et al. Rhabdo-immunodeficiency virus, a murine model of acute HIV-1 infection. elife. 2019;8: pubmed publisher
  6. Swaims Kohlmeier A, Haddad L, Li Z, Brookmeyer K, Baker J, Widom C, et al. Chronic immune barrier dysregulation among women with a history of violence victimization. JCI Insight. 2019;4: pubmed publisher
  7. Lim S, Kim J, Jeon S, Shin M, Kwon J, Kim T, et al. Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients. Front Immunol. 2019;10:496 pubmed publisher
  8. Gonzalo Gil E, Rapuano P, Ikediobi U, Leibowitz R, Mehta S, Coskun A, et al. Transcriptional down-regulation of ccr5 in a subset of HIV+ controllers and their family members. elife. 2019;8: pubmed publisher
  9. Cassetta L, Fragkogianni S, Sims A, Swierczak A, Forrester L, Zhang H, et al. Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets. Cancer Cell. 2019;35:588-602.e10 pubmed publisher
  10. Nishikawa G, Kawada K, Nakagawa J, Toda K, Ogawa R, Inamoto S, et al. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression via CCR5. Cell Death Dis. 2019;10:264 pubmed publisher
  11. Hailemichael Y, Woods A, Fu T, He Q, Nielsen M, Hasan F, et al. Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy. J Clin Invest. 2018;128:1338-1354 pubmed publisher
  12. Krogh Nielsen M, Hector S, Allen K, Subhi Y, Sørensen T. Altered activation state of circulating neutrophils in patients with neovascular age-related macular degeneration. Immun Ageing. 2017;14:18 pubmed publisher
  13. Dias J, Leeansyah E, Sandberg J. Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines. Proc Natl Acad Sci U S A. 2017;114:E5434-E5443 pubmed publisher
  14. Tong A, Hashem H, Eid S, Allen F, Kingsley D, Huang A. Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma. Oncoimmunology. 2017;6:e1303586 pubmed publisher
  15. Cenker J, Stultz R, McDonald D. Brain Microglial Cells Are Highly Susceptible to HIV-1 Infection and Spread. AIDS Res Hum Retroviruses. 2017;33:1155-1165 pubmed publisher
  16. Buskermolen J, Roffel S, Gibbs S. Stimulation of oral fibroblast chemokine receptors identifies CCR3 and CCR4 as potential wound healing targets. J Cell Physiol. 2017;232:2996-3005 pubmed publisher
  17. Park R, Wang T, Koundakjian D, Hultquist J, Lamothe Molina P, Monel B, et al. A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors. Nat Genet. 2017;49:193-203 pubmed publisher
  18. Garcia Mesa Y, Jay T, Checkley M, Luttge B, Dobrowolski C, Valadkhan S, et al. Immortalization of primary microglia: a new platform to study HIV regulation in the central nervous system. J Neurovirol. 2017;23:47-66 pubmed publisher
  19. Cuff A, Robertson F, Stegmann K, Pallett L, Maini M, Davidson B, et al. Eomeshi NK Cells in Human Liver Are Long-Lived and Do Not Recirculate but Can Be Replenished from the Circulation. J Immunol. 2016;197:4283-4291 pubmed
  20. Dyer W, Tan J, Day T, Kiers L, Kiernan M, Yiannikas C, et al. Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. Brain Behav. 2016;6:e00516 pubmed
  21. Byrareddy S, Arthos J, Cicala C, Villinger F, Ortiz K, Little D, et al. Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy. Science. 2016;354:197-202 pubmed
  22. Park A, Hong P, Won S, Thibault P, Vigant F, Oguntuyo K, et al. Sendai virus, an RNA virus with no risk of genomic integration, delivers CRISPR/Cas9 for efficient gene editing. Mol Ther Methods Clin Dev. 2016;3:16057 pubmed publisher
  23. Qian Y, Li C, Jiang A, Ge S, Gu P, Fan X, et al. HIV-1 gp120 Glycoprotein Interacting with Dendritic Cell-specific Intercellular Adhesion Molecule 3-grabbing Non-integrin (DC-SIGN) Down-Regulates Tight Junction Proteins to Disrupt the Blood Retinal Barrier and Increase Its Permeability. J Biol Chem. 2016;291:22977-22987 pubmed
  24. Paquin Proulx D, Gibbs A, Bachle S, Checa A, Introini A, Leeansyah E, et al. Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion. J Immunol. 2016;197:1843-51 pubmed publisher
  25. Pinilla Vera M, Xiong Z, Zhao Y, Zhao J, Donahoe M, Barge S, et al. Full Spectrum of LPS Activation in Alveolar Macrophages of Healthy Volunteers by Whole Transcriptomic Profiling. PLoS ONE. 2016;11:e0159329 pubmed publisher
  26. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed publisher
  27. Neumann B, Shi T, Gan L, Klippert A, Daskalaki M, Stolte Leeb N, et al. Comprehensive panel of cross-reacting monoclonal antibodies for analysis of different immune cells and their distribution in the common marmoset (Callithrix jacchus). J Med Primatol. 2016;45:139-46 pubmed publisher
  28. Najera J, Bustamante E, Bortell N, Morsey B, Fox H, Ravasi T, et al. Methamphetamine abuse affects gene expression in brain-derived microglia of SIV-infected macaques to enhance inflammation and promote virus targets. BMC Immunol. 2016;17:7 pubmed publisher
  29. Moura J, Rodrigues J, Goncalves M, Amaral C, Lima M, Carvalho E. Impaired T-cell differentiation in diabetic foot ulceration. Cell Mol Immunol. 2017;14:758-769 pubmed publisher
  30. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  31. Li X, Yuan Z, Wei X, Li H, Zhao G, Miao J, et al. Application potential of bone marrow mesenchymal stem cell (BMSCs) based tissue-engineering for spinal cord defect repair in rat fetuses with spina bifida aperta. J Mater Sci Mater Med. 2016;27:77 pubmed publisher
  32. Veazey R, Pilch Cooper H, Hope T, Alter G, Carias A, Sips M, et al. Prevention of SHIV transmission by topical IFN-β treatment. Mucosal Immunol. 2016;9:1528-1536 pubmed publisher
  33. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  34. Paris R, Petrovas C, Ferrando Martinez S, Moysi E, Boswell K, Archer E, et al. Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression. PLoS ONE. 2015;10:e0144767 pubmed publisher
  35. Dang Y, Jia G, Choi J, Ma H, Anaya E, Ye C, et al. Optimizing sgRNA structure to improve CRISPR-Cas9 knockout efficiency. Genome Biol. 2015;16:280 pubmed publisher
  36. Heigele A, Joas S, Regensburger K, Kirchhoff F. Increased susceptibility of CD4+ T cells from elderly individuals to HIV-1 infection and apoptosis is associated with reduced CD4 and enhanced CXCR4 and FAS surface expression levels. Retrovirology. 2015;12:86 pubmed publisher
  37. Adoro S, Cubillos Ruiz J, Chen X, Deruaz M, Vrbanac V, Song M, et al. IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infection. Nat Commun. 2015;6:7562 pubmed publisher
  38. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed publisher
  39. Mock U, Machowicz R, Hauber I, Horn S, Abramowski P, Berdien B, et al. mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5. Nucleic Acids Res. 2015;43:5560-71 pubmed publisher
  40. Li C, Guan X, Du T, Jin W, Wu B, Liu Y, et al. Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9. J Gen Virol. 2015;96:2381-93 pubmed publisher
  41. Claiborne D, Prince J, Scully E, Macharia G, Micci L, Lawson B, et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proc Natl Acad Sci U S A. 2015;112:E1480-9 pubmed publisher
  42. Perrigue P, Silva M, Warden C, Feng N, Reid M, Mota D, et al. The histone demethylase jumonji coordinates cellular senescence including secretion of neural stem cell-attracting cytokines. Mol Cancer Res. 2015;13:636-50 pubmed publisher
  43. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed publisher
  44. Matsuda K, Hattori S, Kariya R, Komizu Y, Kudo E, Goto H, et al. Inhibition of HIV-1 entry by the tricyclic coumarin GUT-70 through the modification of membrane fluidity. Biochem Biophys Res Commun. 2015;457:288-94 pubmed publisher
  45. Campbell J, Ratai E, Autissier P, Nolan D, Tse S, Miller A, et al. Anti-?4 antibody treatment blocks virus traffic to the brain and gut early, and stabilizes CNS injury late in infection. PLoS Pathog. 2014;10:e1004533 pubmed publisher
  46. Mandl M, Schmitz S, Weber C, Hristov M. Characterization of the CD14++CD16+ monocyte population in human bone marrow. PLoS ONE. 2014;9:e112140 pubmed publisher
  47. Rogacev K, Zawada A, Hundsdorfer J, Achenbach M, Held G, Fliser D, et al. Immunosuppression and monocyte subsets. Nephrol Dial Transplant. 2015;30:143-53 pubmed publisher
  48. Mylvaganam G, Velu V, Hong J, Sadagopal S, Kwa S, Basu R, et al. Diminished viral control during simian immunodeficiency virus infection is associated with aberrant PD-1hi CD4 T cell enrichment in the lymphoid follicles of the rectal mucosa. J Immunol. 2014;193:4527-36 pubmed publisher
  49. Kudernatsch R, Letsch A, Guerreiro M, Löbel M, Bauer S, Volk H, et al. Human bone marrow contains a subset of quiescent early memory CD8(+) T cells characterized by high CD127 expression and efflux capacity. Eur J Immunol. 2014;44:3532-42 pubmed publisher
  50. Hu H, Eller M, Zafar S, Zhou Y, Gu M, Wei Z, et al. Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals. Proc Natl Acad Sci U S A. 2014;111:13439-44 pubmed publisher
  51. Matsuda K, Dang Q, Brown C, Keele B, Wu F, Ourmanov I, et al. Characterization of simian immunodeficiency virus (SIV) that induces SIV encephalitis in rhesus macaques with high frequency: role of TRIM5 and major histocompatibility complex genotypes and early entry to the brain. J Virol. 2014;88:13201-11 pubmed publisher
  52. Kleppa E, Ramsuran V, Zulu S, Karlsen G, Bere A, Passmore J, et al. Effect of female genital schistosomiasis and anti-schistosomal treatment on monocytes, CD4+ T-cells and CCR5 expression in the female genital tract. PLoS ONE. 2014;9:e98593 pubmed publisher
  53. Cartwright E, McGary C, Cervasi B, Micci L, Lawson B, Elliott S, et al. Divergent CD4+ T memory stem cell dynamics in pathogenic and nonpathogenic simian immunodeficiency virus infections. J Immunol. 2014;192:4666-73 pubmed publisher
  54. Hodara V, Parodi L, Chavez D, Smith L, Lanford R, Giavedoni L. Characterization of ??T cells in naïve and HIV-infected chimpanzees and their responses to T-cell activators in vitro. J Med Primatol. 2014;43:258-71 pubmed publisher